J. Torres-Roca

发表

RbAp48 regulates cytoskeletal organization and morphology by increasing K-Ras activity and signaling through mitogen-activated protein kinase.

T. Yeatman, R. Jove, A. Scuto, 2007, Cancer research.

Validation of a Radiosensitivity Molecular Signature in Breast Cancer

Yudi Pawitan, Steven A. Eschrich, William J. Fulp, 2012, Clinical Cancer Research.

A molecular assay of tumor radiosensitivity: a roadmap towards biology-based personalized radiation therapy.

J. Torres-Roca, Javier F Torres-Roca, 2012, Personalized medicine.

A gene expression platform to predict benefit from adjuvant external beam radiation in resected non-small cell lung cancer

S. Eschrich, J. Torres-Roca, T. Dilling, 2014, medRxiv.

A Molecular Signature of Radiosensitivity (RSI) is an RT-specific Biomarker in Prostate Cancer

S. Eschrich, J. Torres-Roca, E. Davicioni, 2014 .

A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study.

Jacob G. Scott, Eric Mellon, Eduardo Moros, 2017, The Lancet. Oncology.

Utilizing the Radiosensitivity Index (RSI) to Predict Pelvic Failure in Endometrial Cancer Treated with Adjuvant Radiotherapy.

S. Eschrich, R. Wenham, J. Torres-Roca, 2019, International journal of radiation oncology, biology, physics.

Radiosensitivity of Lung Metastases by Primary Histology and Implications for Stereotactic Body Radiation Therapy Using the Genomically Adjusted Radiation Dose

Jacob G. Scott, S. Eschrich, J. Torres-Roca, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Radiosensitivity Differences Between Liver Metastases Based on Primary Histology Suggest Implications for Clinical Outcomes After Stereotactic Body Radiation Therapy.

S. Eschrich, J. Torres-Roca, B. Yue, 2016, International journal of radiation oncology, biology, physics.

Differences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient Selection.

S. Eschrich, J. Torres-Roca, T. Dilling, 2014, International journal of radiation oncology, biology, physics.

Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

A. Halpern, S. Swetter, M. Ross, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Personalized medicine for radiation therapy.

S. Eschrich, J. Torres-Roca, J. Caudell, 2013, Personalized medicine.

Modeling precision genomic-based radiation dose response in rectal cancer.

J. Torres-Roca, M. Schell, S. Hoffe, 2020, Future oncology.

The role of external-beam radiation therapy in the treatment of clinically localized prostate cancer.

J. Torres-Roca, 2006, Cancer control : journal of the Moffitt Cancer Center.

Tumor Radiosensitivity is Associated with Immune Activation in Solid Tumors

S. Eschrich, D. Coppola, A. Giuliano, 2018 .

The future of personalised radiotherapy for head and neck cancer.

Eduardo G Moros, Heiko Enderling, Robert J Gillies, 2017, The Lancet. Oncology.

Management of Sentinel Lymph Node Metastasis in Merkel Cell Carcinoma: Completion Lymphadenectomy, Radiation, or Both?

V. Sondak, J. Torres-Roca, R. Gonzalez, 2018, Annals of Surgical Oncology.

Improved local and regional control with radiotherapy for Merkel cell carcinoma of the head and neck

V. Sondak, T. Strom, J. Torres-Roca, 2017, Head & neck.

Primary tumors from mucosal barrier organs drive unique eosinophil infiltration patterns and clinical associations

S. Eschrich, J. Torres-Roca, A. Munitz, 2020, Oncoimmunology.

Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization

Jacob G. Scott, John E. Mullinax, J. Torres-Roca, 2021, Translational oncology.

The radiosensitivity of brain metastases based upon primary histology utilizing a multigene index of tumor radiosensitivity.

S. Eschrich, J. Torres-Roca, P. Johnstone, 2017, Neuro-oncology.

Letter Response.

Jacob G. Scott, M. Kattan, J. Torres-Roca, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Serial assessment of lymphocytes and apoptosis in the prostate during coordinated intraprostatic dendritic cell injection and radiotherapy.

Jacob G. Scott, J. Pow-Sang, M. Fishman, 2012, Immunotherapy.

Interleukin-1β Converting Enzyme–like Protease Involvement in Fas-induced and Activation-induced Peripheral Blood T Cell Apoptosis in HIV Infection. TNF-related Apoptosis-inducing Ligand Can Mediate Activation-induced T Cell Death in HIV Infection

J. Torres-Roca, L. Herzenberg, L. Herzenberg, 1997, The Journal of experimental medicine.

GARD is a pan-cancer predictor of clinical outcome in radiation treated patients.

M. Kattan, S. Eschrich, J. Torres-Roca, 2020, medRxiv.

Optimizing Clinical Outcome and Toxicity in Lung Cancer Using a Genomic Marker of Radiosensitivity

Jacob G. Scott, M. Kattan, S. Eschrich, 2020 .

Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity and Normal Tissue Toxicity in Non-Small Cell Lung Cancer.

Jacob G. Scott, M. Kattan, S. Eschrich, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Melanoma, version 2.2016 clinical practice guidelines in oncology

A. Halpern, S. Swetter, M. Ross, 2016 .

The early intracellular production of a reactive oxygen intermediate mediates apoptosis in dexamethasone-treated thymocytes.

J. Torres-Roca, C. Amatore, H. Lecoeur, 1995, Cell death and differentiation.

HIV type 1 Tat protein enhances activation-but not Fas (CD95)-induced peripheral blood T cell apoptosis in healthy individuals.

J. Torres-Roca, L. Herzenberg, P. Katsikis, 1997, International immunology.

Utilizing the Radiosensitivity Index (RSI) to Predict Pelvic Failure in Endometrial Cancer Treated with Adjuvant Radiotherapy

S. Eschrich, R. Wenham, J. Torres-Roca, 2019, International Journal of Radiation Oncology*Biology*Physics.

Exploiting convergent evolution to derive a pan-cancer cisplatin response gene expression signature

S. Eschrich, J. Torres-Roca, Dhawan, 2022 .

Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the VanDAAM study

J. Torres-Roca, S. Vadaparampil, A. Naghavi, 2022, Cancer medicine.

Bladder preservation protocols in the treatment of muscle-invasive bladder cancer.

J. Torres-Roca, 2004, Cancer control : journal of the Moffitt Cancer Center.

Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis.

Jacob G. Scott, M. Kattan, S. Eschrich, 2021, The Lancet. Oncology.

Novel Genomic-Based Strategies to Personalize Lymph Node Radiation Therapy.

J. Torres-Roca, L. Harrison, A. Naghavi, 2019, Seminars in radiation oncology.

Radiation Therapy is Associated with Improved Outcomes in Merkel Cell Carcinoma

V. Sondak, T. Strom, J. Torres-Roca, 2016, Annals of Surgical Oncology.

Tumour radiosensitivity is associated with immune activation in solid tumours.

S. Eschrich, J. Foekens, D. Coppola, 2017, European journal of cancer.

The radiosensitivity index predicts for overall survival in glioblastoma

Steven Eschrich, William J Fulp, Prakash Chinnaiyan, 2015, Oncotarget.

Regional Radiation Therapy Impacts Outcome for Node-Positive Cutaneous Melanoma.

V. Sondak, T. Strom, S. Eschrich, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

Harnessing Tumor Immune Ecosystem Dynamics to Personalize Radiation Therapy

S. Eschrich, J. Torres-Roca, J. Cleveland, 2020 .

Harnessing tumor immune ecosystem dynamics to personalize radiotherapy

S. Eschrich, J. Torres-Roca, J. Cleveland, 2020, bioRxiv.

An Early Oxygen-Dependent Step Is Required for Dexamethasone-Induced Apoptosis of Immature Mouse Thymocytes1

J. Torres-Roca, L. Herzenberg, L. Herzenberg, 2000, The Journal of Immunology.

Apoptosis of Immature Mouse Thymocytes Required for Dexamethasone-Induced An Early Oxygen-Dependent Step Is

J. Torres-Roca, L. Herzenberg, P. Katsikis, 2000 .

Integrating Biological Covariates into Gene Expression-Based Predictors of Radiation Sensitivity

S. Eschrich, J. Torres-Roca, Vidya P Kamath, 2017, International journal of genomics.

Regulates Cytoskeletal Organization and Morphology by Increasing KRas Activity and Signaling through Mitogen-Activated Protein Kinase

T. Yeatman, R. Jove, A. Scuto, 2007 .

Genomic testing in localized prostate cancer can identify subsets of African-Americans with aggressive disease.

Jordan H. Creed, T. Rebbeck, J. Torres-Roca, 2022, Journal of the National Cancer Institute.

GARD is a pan-cancer predictor of radiation therapy benefit

Jacob G. Scott, M. Kattan, S. Eschrich, 2020 .

Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference.

C. N. Coleman, Reid F Thompson, J. Weidhaas, 2017, International journal of radiation oncology, biology, physics.

Systems biology modeling of the radiation sensitivity network: a biomarker discovery platform.

Steven Eschrich, David Boulware, Ji-Hyun Lee, 2009, International journal of radiation oncology, biology, physics.

Prediction of radiation sensitivity using a gene expression classifier.

Steven Eschrich, Timothy Yeatman, T. Yeatman, 2005, Cancer research.

Activated STAT3 as a correlate of distant metastasis in prostate cancer: a secondary analysis of Radiation Therapy Oncology Group 86-10.

R. Jove, J. Torres-Roca, H. Sandler, 2007, Urology.

Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer management

Jacob G. Scott, S. Eschrich, J. Torres-Roca, 2019, EBioMedicine.

NCCN Guidelines® insights: Melanoma, version 3.2016: Featured updates to the NCCN Guidelines

Brian R. Gastman, Kenneth K. Tanabe, Christopher K. Bichakjian, 2016 .

Treatment of intermediate-risk prostate cancer with brachytherapy without supplemental pelvic radiotherapy: a review of the H. Lee Moffitt Cancer Center experience.

J. Pow-Sang, J. Friedland, J. Torres-Roca, 2006, Urologic oncology.

Predicting response to clinical radiotherapy: past, present, and future directions.

J. Torres-Roca, Javier F Torres-Roca, Craig W Stevens, 2008, Cancer control : journal of the Moffitt Cancer Center.

Personalizing Radiation Treatment Delivery in the Management of Breast Cancer

J. Torres-Roca, B. Czerniecki, H. Soliman, 2018, International journal of breast cancer.

Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer.

M. J. van de Vijver, S. Eschrich, M. Bollet, 2015, International journal of radiation oncology, biology, physics.

Radiosensitivity index predicts for survival with adjuvant radiation in resectable pancreatic cancer.

T. Strom, S. Eschrich, D. Coppola, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation.

David Boulware, Ji-Hyun Lee, T. Yeatman, 2009, International journal of radiation oncology, biology, physics.

Changing Radiotherapy Paradigms in Penile Cancer.

Jacob G. Scott, J. Torres-Roca, P. Spiess, 2022, European urology open science.

Radiotherapy with genomic-adjusted radiation dose - Authors' reply.

Jacob G. Scott, M. Kattan, J. Torres-Roca, 2021, The Lancet. Oncology.

Response to: Noncancer Cells in Tumor Samples May Bias the Predictive Genomically Adjusted Radiation Dose.

Jacob G. Scott, M. Kattan, J. Torres-Roca, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Genomically Guided Breast Radiation Therapy: A Review of the Current Data and Future Directions

W. Woodward, J. Torres-Roca, E. Harris, 2021, Advances in radiation oncology.

Radiation therapy in the management of the inguinal region in penile cancer: What's the evidence?

J. Torres-Roca, P. Spiess, P. Johnstone, 2020, Urologic oncology.

Intrinsic radiosensitivity, genomic-based radiation dose and patterns of failure of penile cancer in response to adjuvant radiation therapy.

A. Giuliano, J. Torres-Roca, P. Spiess, 2019, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Genomic-adjusted radiation dose - Authors' reply.

Jacob G. Scott, J. Torres-Roca, L. Harrison, 2017, The Lancet. Oncology.

Prediction of Radiation Sensitivity Using a Gene

T. Yeatman, S. Eschrich, R. Jove, 2005 .

Interferon is associated with improved survival for node-positive cutaneous melanoma: a single-institution experience

V. Sondak, T. Strom, J. Torres-Roca, 2018, Melanoma management.

Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and exploratory analysis

J. Torres-Roca, D. Hunt, K. Latifi, 2020, Prostate Cancer and Prostatic Diseases.

Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and exploratory analysis

J. Pow-Sang, J. Torres-Roca, D. Hunt, 2020, Prostate Cancer and Prostatic Diseases.

NCCN Guidelines Insights: Melanoma, Version 3.2016.

Merrick I Ross, Susan M Swetter, Brian Gastman, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation

Kujtim Latifi, Eduardo G. Moros, Jan Poleszczuk, 2015, Radiation Oncology.

Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408.

Christopher U. Jones, J. Torres-Roca, H. Sandler, 2015, International journal of radiation oncology, biology, physics.

Prostatic Artery Embolization Is Safe and Effective for Medically Recalcitrant Radiation-Induced Prostatitis

J. Pow-Sang, J. Torres-Roca, D. Boulware, 2020, Advances in radiation oncology.

Technological Advancements in Radiation Dose Delivery : From Two-Dimensional Radiotherapy to Image-Guided Radiotherapy

J. Torres-Roca, 2006 .

RSI: A genomic signature of radiosensitivity

Jacob G. Scott, S. Eschrich, J. Torres-Roca, 2016 .

A dosimetric analysis of unstranded seeds versus customized stranded seeds in transperineal interstitial permanent prostate seed brachytherapy.

J. Pow-Sang, J. Torres-Roca, C. Gwede, 2006, Brachytherapy.

Non-Adaptive MR-Guided Radiotherapy for Prostate SBRT: Less Time, Equal Results

J. Torres-Roca, K. Latifi, P. Johnstone, 2021, Journal of clinical medicine.

Perceptions of Prostate Cancer Screening Controversy and Informed Decision Making: Implications for Development of a Targeted Decision Aid for Unaffected Male First-Degree Relatives

J. Pow-Sang, Daohai Yu, J. Torres-Roca, 2015, American journal of health promotion : AJHP.

Effectiveness and safety of prostatic artery embolization for the treatment of lower urinary tract symptoms from benign prostatic hyperplasia in men with concurrent localized prostate cancer.

J. Pow-Sang, S. Feuerlein, J. Torres-Roca, 2021, Journal of vascular and interventional radiology : JVIR.

Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease.

J. Torres-Roca, K. Ahmed, 2016, Cancer control : journal of the Moffitt Cancer Center.

Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature

Jacob G. Scott, S. Eschrich, J. Torres-Roca, 2023, NPJ precision oncology.

Exploiting convergent evolution to derive a pan-cancer cisplatin sensitivity gene expression signature

S. Eschrich, J. Torres-Roca, A. Dhawan, 2021, medRxiv.

Informed decision making among first-degree relatives of prostate cancer survivors: a pilot randomized trial.

J. Pow-Sang, J. Torres-Roca, C. Gwede, 2014, Contemporary clinical trials.

Tumor-immune ecosystem dynamics define an individual Radiation Immune Score to predict pan-cancer radiocurability

S. Eschrich, J. Torres-Roca, J. Cleveland, 2021, Neoplasia.

Proliferation Saturation Index Predicts Oropharyngeal Squamous Cell Cancer Gross Tumor Volume Reduction to Prospectively Identify Patients for Adaptive Radiation Therapy

Kujtim Latifi, Eduardo G. Moros, Helen M. Byrne, 2016 .

Towards Data Driven RT Prescription: Integrating Genomics into RT Clinical Practice.

S. Eschrich, J. Torres-Roca, J. Scott, 2023, Seminars in radiation oncology.

The Radiosensitivity Index (RSI) Gene Signature Identifies Distinct Tumor Immune Microenvironment Characteristics Associated with Susceptibility to Radiotherapy.

S. Eschrich, J. Torres-Roca, J. Cleveland, 2022, International journal of radiation oncology, biology, physics.

Novel Transcriptomic Interactions Between Immune Content and Genomic Classifier Predict Lethal Outcomes in High-grade Prostate Cancer.

T. Rebbeck, J. Pow-Sang, J. Torres-Roca, 2020, European urology.

Genomics and radiomics: Tools to see the unseen to personalize radiation therapy

S. Eschrich, J. Torres-Roca, M. Mills, 2019, Applied Radiation Oncology.

Radiosensitivity differences between liver metastases based on primary histology suggest implications for clinical outcomes following SBRT.

S. Eschrich, J. Torres-Roca, A. Berglund, 2016 .

EP-2302: Differences in the Radiosensitivty Index (RSI) Between Metastatic and Primary Breast Cancer

J. Torres-Roca, K. Ahmed, R. Diaz, 2018 .

Genomic biomarkers for precision radiation medicine - Authors' reply.

Jacob G. Scott, J. Torres-Roca, L. Harrison, 2017, The Lancet. Oncology.

Radiosensensitivity Index Shows Promise for Predicting Outcomes With Adjuvant Radiation in Resected Pancreatic Cancer Patients

T. Strom, S. Eschrich, D. Coppola, 2014 .

Radiosensitivity Molecular Signature Is Predictive of Overall Survival in Glioblastoma

S. Eschrich, J. Torres-Roca, J. Caudell, 2014 .

Inhibition of STAT3 activity with STAT3 antisense oligonucleotide (STAT3-ASO) enhances radiation-induced apoptosis in DU145 prostate cancer cells

R. Jove, J. Torres-Roca, M. Sekharam, 2003 .

Systems biology modeling of the radiation sensitivity network: a biomarker discovery platform.

S. Eschrich, Hongling Zhang, Haiyan Zhao, 2009, International journal of radiation oncology, biology, physics.

NCCN Guidelines Insights: Melanoma, Version 3.2016.

S. Swetter, M. Ross, J. Torres-Roca, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity and Normal Tissue Toxicity in Non-Small Cell Lung Cancer.

M. Kattan, S. Eschrich, J. Torres-Roca, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

4 Bone Sarcoma ... Turning the Corner

Shawna V. Hudson, V. Sondak, G. Bepler, 2008 .

Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma

J. Torres-Roca, K. Latifi, V. Feygelman, 2024, BMC cancer.

Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer.

M. J. van de Vijver, S. Eschrich, M. Bollet, 2015, International journal of radiation oncology, biology, physics.

Abstract 678: Validation of a radiosensitivity molecular signature in breast cancer

Y. Pawitan, J. Bergh, S. Eschrich, 2012 .